Industry News & Trends

DISA’s insights, tips, and trends cover various topics from human capital management to compliance updates for background screening, drug & alcohol testing, and more. These articles are written by DISA experts and partners worldwide. We highlight the issues and topics that have an impact on the hiring process.

square-pattern dots
sDISA's Industry News & Trends
circular-pattern dots
caffeine slump dozing off at work

Caffeine Crackdown: Is Your Morning Cup of Joe in Danger?

DISA's 2018 April Fools Joke: Companies nationwide are considering cracking down on your morning cup of joe. Caffeine is consumed on a daily basis by the majority of U.S. workers in a variety of ways including coffee, energy drinks, chocolate, caffeine pills, tea, etc. Those quick pick-me-ups might soon be a thing of the past as employers are considering drug testing for caffeine

Several large companies in the U.S. have recently begun exploratory drug testing for caffeine, under the belief that the short-term benefits, don’t outweigh the long-term risks.

Truck driving on a dark and winding road at night

Hats Off to Safer Driving: Workplace Safety Insights

Learn how employers can promote safer driving practices and improve workplace safety with effective driver safety programs.

Drugs in pill form and syringe form

The Next Gateway Drug: How Prescription Drugs Have Started a New Epidemic

Learn how opioid abuse leads to heroin use and how employers can safeguard their workplace with drug testing and prevention strategies.

cars on a highway

All Hail Advanced Screening Processes

Informed hiring decisions are crucial to the success of all companies, big or small. That belief drives everything we do at DISA—and for ride-hailing services like Uber and Lyft, the emphasis on informed hiring decisions has officially been heightened.

Gloved hands placing a hair into a test vial

Hair Testing Now Allowed in Iowa

Iowa now allows hair testing for drug screening, providing employers with expanded options for workplace drug testing compliance.

filing digital records

Concentra Now Offers eCCF Capabilities for DOT Drug Testing

Concentra, a partner of DISA Global Solutions, now offers Electronic Custody and Control Form (eCCF) capabilities for DOT drug testing across its network of over 310 Occupational Health Clinics nationwide. This digital transition reduces paper usage and errors, leading to up to a 25% improvement in turnaround times. 

drug free workplace sign

The Great Marijuana Expansion: Next Steps For Your Company

Learn how to navigate marijuana legalization and update workplace drug policies to stay compliant and protect your workforce.

Construction working walking around among tools and materials

Establishing a Culture of Safety

Learn strategies to build a strong safety culture in the workplace, improve compliance, and reduce risk across your organization.

Person entering a document into an electronic Chain of Custody (eCCF) platform.

DISA Helps Clients Transform Paper Chain of Custody Process into An Electronic Solution

DISA helps clients switch from paper to electronic Chain of Custody, streamlining drug testing, improving efficiency, and ensuring compliance.

person pushing a keyboard button labeled "Drug Testing"

PHMSA Increases Random Drug Testing Rate from 25 Percent to 50 Percent

PHMSA raises random drug testing rate from 25% to 50% for 2018 due to industry positive rates. Learn how this impacts employer compliance.

drug testing in lab

2017 Owners Report Analysis: Collection Process

The following information reflects a combination of data collected from DISA Global Solutions’ 2017 Owners Survey, which was sent to several upstream and downstream owners.

These survey results help DISA stay on top of growing trends within the drug and alcohol testing industry, and provide clients with services that are customized to their needs.

Vials of liquid in a lab drug test

2017 Owners Report Analysis: Synthetics, Opioids, & Marijuana Testing

Explore key findings from the 2017 Owner’s Report on drug testing trends, including synthetic opioids, marijuana, and workplace safety impacts.